Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility and Safety of Targeting Neutral vs Liberal Fluid Balance in Traumatic Brain Injured Patients: a Phase II Randomized Controlled Trial - LIMIT-TBI Trial

NCT07625995 is registered in ClinicalTrials.gov with Erasme University Hospital as lead sponsor.

NCT NCT07625995
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07625995 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility and Safety of Targeting Neutral vs Liberal Fluid Balance in Traumatic Brain Injured Patients: a Phase II Randomized Controlled Trial - LIMIT-TBI Trial
Lead sponsor
Erasme University Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
July 1, 2025
Completion date
February 28, 2029
Enrollment
88 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

acute brain injury, neurocritical care, severe traumatic brain injury, traumatic brain injury